Abstract
A 40-year-old male developed 66 months after diagnosis of Hodgkin's disease a non-Hodgkin lymphoma of high grade malignancy. Initially he had been treated by irradiation because of Hodgkin's disease PS IIA. After 2 years of remission he had relapsed and had received MOPP and CCNU. After 2 years without any therapy he developed the secondary neoplasm. With increasing frequency of long term survivors late complications, either therapy related or caused by immunologic defects, are observed.
MeSH terms
-
Adult
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols*
-
Cisplatin / therapeutic use
-
Hodgkin Disease / complications*
-
Hodgkin Disease / drug therapy
-
Humans
-
Laparotomy
-
Lomustine / therapeutic use
-
Lymphoma / etiology*
-
Lymphoma / therapy
-
Male
-
Mechlorethamine / administration & dosage
-
Methotrexate / therapeutic use
-
Neoplasm Recurrence, Local
-
Neoplasm Staging
-
Prednisone / administration & dosage
-
Procarbazine / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Antineoplastic Agents
-
Procarbazine
-
Mechlorethamine
-
Vincristine
-
Lomustine
-
Cisplatin
-
Prednisone
-
Methotrexate